Skip to content

From bench to patient: collaborating on drug development

At the Therapeutic Development Workshop, experts shared perspectives on the challenges of moving a therapy from basic research discovery to the clinic - exploring all stages of therapeutic development.

Led by UNSW Medicine and funded by the Cancer Theme and (Maridulu Budyari Gumal [SPHERE] Cancer CAG), the workshop enabled experts across all steps of drug development and the SPHERE partnership to explore ideas around commercialising research into treatments, therapies or drugs to improve health across the community.

Leader of the Translational Cancer Metabolism Laboratory in the Adult Cancer Program at UNSW, A/Prof Jeff Holst explained, “The take home message reiterated by many speakers was that we need to fail fast by doing the right commercial grade assays early in our drug development pipeline. This will save time and money and ensure we develop the best drug candidate.”

A video of the entire workshop is available here, including a handy shortcut table to take you to the speaker or section you want to view.

News about the workshop can be accessed here

Raising the consumer and community voice

The Cancer Clinical Academic Group Management Committee has increased its consumer and community membership to three people. This recent change acknowledges the value of different perspectives and how lived experiences can strengthen the quality and relevance of health and medical research.

Reaching those who need it most with a COVID-19 message they can understand and act upon.

Maridul Budyari Gumal has joined forces with the NSW Multicultural Health Communication Service in consultation with NSW Health to create a series of 36 fact sheets containing medical advice and instructions covering Arthritis, Asthma, Cardiovascular Health, Diabetes and Stroke translated into Arabic, Chinese, Chinese (Standard and Simplified), Greek, Italian and Vietnamese.

UNSW Wins International COVID-19 Data Science Competition

UNSW Sydney academics have been recognised for their open-source COVOID software built to model COVID-19 transmission and intervention strategies.